These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3056203)

  • 1. New chemotherapeutic approaches in the treatment of Lyme borreliosis.
    Luft BJ; Volkman DJ; Halperin JJ; Dattwyler RJ
    Ann N Y Acad Sci; 1988; 539():352-61. PubMed ID: 3056203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic treatment of Lyme borreliosis.
    Dattwyler RJ; Luft BJ
    Biomed Pharmacother; 1989; 43(6):421-6. PubMed ID: 2686769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin.
    Dattwyler RJ; Halperin JJ; Volkman DJ; Luft BJ
    Lancet; 1988 May; 1(8596):1191-4. PubMed ID: 2897008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone--An effective treatment of late Lyme borreliosis.
    Luft BJ; Halperin JJ; Volkman DJ; Dattwyler RJ
    J Chemother; 1989 Jul; 1(4 Suppl):917-9. PubMed ID: 16312703
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis.
    Weber K; Preac-Mursic V; Wilske B; Thurmayr R; Neubert U; Scherwitz C
    Infection; 1990; 18(2):91-6. PubMed ID: 2185158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy problems of Lyme borreliosis].
    Schmutzhard E
    Padiatr Padol; 1989; 24(1):63-8. PubMed ID: 2654818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibiotic therapy of Lyme borreliosis].
    Satz N; Knoblauch M
    Schweiz Med Wochenschr; 1990 Feb; 120(7):209-16. PubMed ID: 2408142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents.
    Johnson RC; Kodner C; Russell M
    Antimicrob Agents Chemother; 1987 Feb; 31(2):164-7. PubMed ID: 3566246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment and follow up of disseminated and late Lyme disease].
    Mohseni Zadeh M
    Med Mal Infect; 2007; 37(7-8):368-80. PubMed ID: 17707605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy of treatments for early syphilis: A systematic review and network meta-analysis of randomized controlled trials and observational studies.
    Liu HY; Han Y; Chen XS; Bai L; Guo SP; Li L; Wu P; Yin YP
    PLoS One; 2017; 12(6):e0180001. PubMed ID: 28658325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of ceftriaxone treatment on intraocular Lyme borreliosis.
    Suttorp-Schulten MS; Kuiper H; Kijlstra A; van Dam AP; Rothova A
    Am J Ophthalmol; 1993 Nov; 116(5):571-5. PubMed ID: 8238216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lyme borreliosis in childhood].
    Millner M
    Padiatr Padol; 1992; 27(6):A81-93. PubMed ID: 1484707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of late Lyme borreliosis.
    Wahlberg P; Granlund H; Nyman D; Panelius J; Seppälä I
    J Infect; 1994 Nov; 29(3):255-61. PubMed ID: 7884218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyme disease: insights into the use of antimicrobials for prevention and treatment in the context of experience with other spirochetal infections.
    Wormser GP
    Mt Sinai J Med; 1995 May; 62(3):188-95. PubMed ID: 7616973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility.
    Preac-Mursic V; Wilske B; Schierz G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Dec; 263(1-2):112-8. PubMed ID: 3577473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of erythema chronicum migrans of Lyme disease.
    Berger BW
    Ann N Y Acad Sci; 1988; 539():346-51. PubMed ID: 3190102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites.
    Kazragis RJ; Dever LL; Jorgensen JH; Barbour AG
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2632-6. PubMed ID: 8913478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells.
    Sharma B; Brown AV; Matluck NE; Hu LT; Lewis K
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4616-24. PubMed ID: 26014929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The diagnosis and treatment of Lyme disease: a report of six cases].
    Liu X; Sheng R; Wang A; Qin S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Aug; 22(4):398-9. PubMed ID: 12903460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of patients with persistent symptoms and a history of Lyme disease.
    Donta ST
    N Engl J Med; 2001 Nov; 345(19):1424; author reply 1425. PubMed ID: 11794180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.